About Osteal Therapeutics
Osteal Therapeutics is a company based in San Clemente (United States) founded in 2013.. Osteal Therapeutics has raised $126.4 million across 7 funding rounds from investors including Zimmer Biomet, Johnson & Johnson Innovation – JJDC and Gideon Strategic Partners. Osteal Therapeutics offers products and services including VT-X7. Osteal Therapeutics operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Horizon Therapeutics, among others.
- Headquarter San Clemente, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Osteal Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$126.4 M (USD)
in 7 rounds
-
Latest Funding Round
$15.6 M (USD), Series D
Oct 17, 2025
-
Investors
Zimmer Biomet
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Osteal Therapeutics
Osteal Therapeutics offers a comprehensive portfolio of products and services, including VT-X7. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medication for treating orthopedic infections through clinical trials.
Unlock access to complete
Funding Insights of Osteal Therapeutics
Osteal Therapeutics has successfully raised a total of $126.4M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $15.6 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series D — $15.6M
-
First Round
First Round
(18 Apr 2018)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series D - Osteal Therapeutics | Valuation |
investors |
|
| May, 2024 | Amount | Series D - Osteal Therapeutics | Valuation | Zimmer Biomet | |
| Sep, 2023 | Amount | Series C - Osteal Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Osteal Therapeutics
Osteal Therapeutics has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Zimmer Biomet, Johnson & Johnson Innovation – JJDC and Gideon Strategic Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are managed by HM Venture Partners.
|
Founded Year | Domain | Location | |
|
Medvest Capital is focused on investing in medical device companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Osteal Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Osteal Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Osteal Therapeutics Comparisons
Competitors of Osteal Therapeutics
Osteal Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Horizon Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Osteal Therapeutics
Frequently Asked Questions about Osteal Therapeutics
When was Osteal Therapeutics founded?
Osteal Therapeutics was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is Osteal Therapeutics located?
Osteal Therapeutics is headquartered in San Clemente, United States. It is registered at San Clemente, California, United States.
Who is the current CEO of Osteal Therapeutics?
David Thompson is the current CEO of Osteal Therapeutics.
Is Osteal Therapeutics a funded company?
Osteal Therapeutics is a funded company, having raised a total of $126.4M across 7 funding rounds to date. The company's 1st funding round was a Series C of $23M, raised on Apr 18, 2018.
What does Osteal Therapeutics do?
Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections. The company lead product VT-X7 is for Periprosthetic joint infection and targets chronic bacterial PJI. Another drug candidate A-103 is for fungal PJI. The company offers its drug-device combination product for antibiotic therapy for local delivery to treat infected joint prostheses like bacterial and fungal infections for joints like shoulder, knee, and hip.
Who are the top competitors of Osteal Therapeutics?
Osteal Therapeutics's top competitors include Merck, Roivant Sciences and AbbVie.
What products or services does Osteal Therapeutics offer?
Osteal Therapeutics offers VT-X7.
Who are Osteal Therapeutics's investors?
Osteal Therapeutics has 8 investors. Key investors include Zimmer Biomet, Johnson & Johnson Innovation – JJDC, Gideon Strategic Partners, HM Venture Partners, and Prism Ventures.